HIV-1 Drug Resistance in the iPrEx Preexposure Prophylaxis Trial

Background. The iPrEx study demonstrated that combination oral emtricitabine and tenofovir disoproxil fumarate (FTC/TDF) as preexposure prophylaxis (PrEP) protects against HIV acquisition in men who have sex with men and transgender women. Selection for drug resistance could offset PrEP benefits. Me...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Liegler, Teri, Abdel-Mohsen, Mohamed, Bentley, L. Gordon, Atchison, Robert, Schmidt, Timothy, Javier, Jacqueline, Mehrotra, Megha, Eden, Christopher, Glidden, David V., McMahan, Vanessa, Anderson, Peter L., Li, Peilin, Wong, Joseph K., Buchbinder, Susan, Guanira, Juan V., Grant, Robert M.
Materialtyp: Artigo
Språk:Inglês
Publicerad: Oxford University Press 2014
Ämnen:
Major Articles and Brief Reports
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4176446/
https://ncbi.nlm.nih.gov/pubmed/24740633
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jiu233
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk